Strategic partnerships Eybna collaborates with beverage manufacturers and R&D partners across major markets (Israel, Netherlands, US, Germany) and has recent collaboration with Azuca, indicating openness to co-development and co-branding opportunities in functional beverages and wellness products.

Clinical-grade capabilities With the BNA AI platform combining in-silico modeling, in-vitro assays, EEG studies, and consumer trials, Eybna offers scientifically validated, pharma-grade botanical ingredients suitable for premium beverage and wellness brands seeking validated claims.

Global reach Operations and R&D presence across multiple regions plus a footprint serving over 53 countries and reaching over 100 million people, enabling faster market access and localized formulations for global brands.

Growth potential Revenue range of 25–50 million with active expansion in the US and Europe, suggesting scalable capacity for new product launches, white-label formulations, and partnerships with craft and large-scale beverage companies.

Innovation pipeline Historical launches and patents around functional lines and NT-VRL formulations indicate a steady stream of new, differentiated ingredients for focus, sleep, mood, and anti-inflammatory/antiviral claims—appealing to wellness and adaptation-focused brands.